These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 15007103)

  • 1. Urotensin-II-converting enzyme activity of furin and trypsin in human cells in vitro.
    Russell FD; Kearns P; Toth I; Molenaar P
    J Pharmacol Exp Ther; 2004 Jul; 310(1):209-14. PubMed ID: 15007103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart.
    Russell FD; Molenaar P
    Cardiovasc Res; 2004 Sep; 63(4):673-81. PubMed ID: 15306223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements for furin-induced cleavage and activation of Shiga toxin.
    Kurmanova A; Llorente A; Polesskaya A; Garred O; Olsnes S; Kozlov J; Sandvig K
    Biochem Biophys Res Commun; 2007 May; 357(1):144-9. PubMed ID: 17407762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effects of human urotensin-II in rats with experimental congestive heart failure.
    Ovcharenko E; Abassi Z; Rubinstein I; Kaballa A; Hoffman A; Winaver J
    Nephrol Dial Transplant; 2006 May; 21(5):1205-11. PubMed ID: 16396970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL-2-induced glioma cell invasiveness depends on furin-like proteases.
    Wick W; Wild-Bode C; Frank B; Weller M
    J Neurochem; 2004 Dec; 91(6):1275-83. PubMed ID: 15584904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the active conformation of urotensin II.
    Carotenuto A; Grieco P; Campiglia P; Novellino E; Rovero P
    J Med Chem; 2004 Mar; 47(7):1652-61. PubMed ID: 15027856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
    Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
    Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta.
    Zhang YG; Li J; Li YG; Wei RH
    J Hypertens; 2008 Jun; 26(6):1119-26. PubMed ID: 18475149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prointegrin maturation follows rapid trafficking and processing of MT1-MMP in Furin-Negative Colon Carcinoma LoVo Cells.
    Deryugina EI; Ratnikov BI; Yu Q; Baciu PC; Rozanov DV; Strongin AY
    Traffic; 2004 Aug; 5(8):627-41. PubMed ID: 15260832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prohormone convertases 1/3, 2, furin and protein 7B2 (Secretogranin V) in endocrine cells of the human pancreas.
    Portela-Gomes GM; Grimelius L; Stridsberg M
    Regul Pept; 2008 Feb; 146(1-3):117-24. PubMed ID: 17959263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of new pharmacophores for nonpeptide antagonists of human urotensin-II. Comparison with the 3D-structure of human urotensin-II and URP.
    Lescot E; Sopkova-de Oliveira Santos J; Dubessy C; Oulyadi H; Lesnard A; Vaudry H; Bureau R; Rault S
    J Chem Inf Model; 2007; 47(2):602-12. PubMed ID: 17381176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ultraviolet radiation on the expression of pp38MAPK and furin in human keratinocyte-derived cell lines.
    Huynh TT; Chan KS; Piva TJ
    Photodermatol Photoimmunol Photomed; 2009 Feb; 25(1):20-9. PubMed ID: 19152512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II.
    Boivin S; Ségalas-Milazzo I; Guilhaudis L; Oulyadi H; Fournier A; Davoust D
    Peptides; 2008 May; 29(5):700-10. PubMed ID: 18423797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of the TGF-beta latency associated peptide region determines the ability of the proprotein convertase furin to cleave TGF-betas.
    Kusakabe M; Cheong PL; Nikfar R; McLennan IS; Koishi K
    J Cell Biochem; 2008 Jan; 103(1):311-20. PubMed ID: 17516499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-amyloid protein converting enzyme 1 and brain-specific type II membrane protein BRI3: binding partners processed by furin.
    Wickham L; Benjannet S; Marcinkiewicz E; Chretien M; Seidah NG
    J Neurochem; 2005 Jan; 92(1):93-102. PubMed ID: 15606899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial purification and characterization of digestive trypsin-like proteases from the velvet bean caterpillar, Anticarsia gemmatalis.
    Oliveira MG; De Simone SG; Xavier LP; Guedes RN
    Comp Biochem Physiol B Biochem Mol Biol; 2005 Mar; 140(3):369-80. PubMed ID: 15694584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of urotensin II and URP.
    Leprince J; Chatenet D; Dubessy C; Fournier A; Pfeiffer B; Scalbert E; Renard P; Pacaud P; Oulyadi H; Ségalas-Milazzo I; Guilhaudis L; Davoust D; Tonon MC; Vaudry H
    Peptides; 2008 May; 29(5):658-73. PubMed ID: 17931747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urotensin-II receptor ligands. From agonist to antagonist activity.
    Grieco P; Carotenuto A; Campiglia P; Marinelli L; Lama T; Patacchini R; Santicioli P; Maggi CA; Rovero P; Novellino E
    J Med Chem; 2005 Nov; 48(23):7290-7. PubMed ID: 16279788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant immunoproapoptotic proteins with furin site can translocate and kill HER2-positive cancer cells.
    Wang T; Zhao J; Ren JL; Zhang L; Wen WH; Zhang R; Qin WW; Jia LT; Yao LB; Zhang YQ; Chen SY; Yang AG
    Cancer Res; 2007 Dec; 67(24):11830-9. PubMed ID: 18089813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.
    Dubessy C; Cartier D; Lectez B; Bucharles C; Chartrel N; Montero-Hadjadje M; Bizet P; Chatenet D; Tostivint H; Scalbert E; Leprince J; Vaudry H; Jégou S; Lihrmann I
    J Neurochem; 2008 Oct; 107(2):361-74. PubMed ID: 18710417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.